tiprankstipranks
Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX
Canadian Market
EPRX
Eupraxia Pharmaceuticals
RESEARCH TOOLSreports

Eupraxia Pharmaceuticals (EPRX) Financial Statements

63 Followers

Eupraxia Pharmaceuticals Financial Overview

Eupraxia Pharmaceuticals's market cap is currently C$605.14M. The company's EPS TTM is C$-0.424; its P/E ratio is -10.51; Eupraxia Pharmaceuticals is scheduled to report earnings on March 13, 2026, and the estimated EPS forecast is C$-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -241.88KC$ -235.25KC$ -209.91KC$ -193.27KC$ -111.53K
Operating IncomeC$ -39.11MC$ -36.99MC$ -36.90MC$ -22.63MC$ -20.87M
EBITDAC$ -38.86MC$ -33.72MC$ -37.40MC$ -22.14MC$ -21.96M
Net IncomeC$ -39.25MC$ -34.94MC$ -37.39MC$ -23.26MC$ -22.99M
Balance Sheet
Cash & Short-Term InvestmentsC$ 80.42MC$ 33.10MC$ 19.34MC$ 24.74MC$ 29.90M
Total AssetsC$ 85.99MC$ 50.24MC$ 26.72MC$ 25.88MC$ 31.22M
Total DebtC$ 154.08KC$ 103.31KC$ 10.45MC$ 10.55MC$ 9.49M
Net DebtC$ -80.26MC$ -33.03MC$ -11.72MC$ -14.19MC$ -11.40M
Total LiabilitiesC$ 5.69MC$ 4.46MC$ 25.55MC$ 14.51MC$ 11.67M
Stockholders' EquityC$ 81.89MC$ 33.40MC$ 2.22MC$ 12.86MC$ 20.39M
Cash Flow
Free Cash FlowC$ -29.65MC$ -30.10MC$ -28.02MC$ -19.08MC$ -15.07M
Operating Cash FlowC$ -29.05MC$ -29.99MC$ -27.92MC$ -18.78MC$ -14.64M
Investing Cash FlowC$ -599.26KC$ -75.16KC$ -99.03KC$ 8.70MC$ -14.45M
Financing Cash FlowC$ 77.39MC$ 45.78MC$ 27.84MC$ 13.52MC$ 49.92M
Currency in CAD

Eupraxia Pharmaceuticals Earnings and Revenue History

Income Statement >

Eupraxia Pharmaceuticals Debt to Assets

Balance Sheet >

Eupraxia Pharmaceuticals Cash Flow

Cash Flow >

Eupraxia Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >